EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Glutamine Fuels De Novo Sphingomyelin Synthesis to Drive Hepatocellular Carcinoma Development

Qin Huang, Zhitian Shi, Jian Zhao, Xianjiao Mao, Zhihong Tu, Yiwen Zhang, Yue Sun, Huiling Zhu, Chen Zhao, Peng Yang, Chen Zhang, Jiashun Xu und 10 weitere

Advanced Science · 18.11.2026

DOI: 10.1002/advs.78828 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 18.11.2026. Verfasst von Qin Huang und 21 weiteren Autor:innen. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Kunming Medical University, Yunnan University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although metabolic reprogramming is a recognized hallmark of cancer, the specific metabolic pathways driving hepatocellular carcinoma (HCC) development remain incompletely understood. Through metabolomic profiling of human HCC specimens, we reveal that amino acids and their analogues are the most profoundly dysregulated metabolites, with glutamine being notably depleted within the tumor microenvironment. Despite its perception as a generic nutrient, we demonstrate that dietary glutamine supplementation promotes the malignant transformation of tumor progenitors and accelerates proliferation in oncogene‐driven murine models, ultimately compromising overall survival. Metabolomic and 13 C‐isotope tracing analyses indicate that glutamine is preferentially channeled into de novo sphingomyelin (SM) synthesis. Both genetic and pharmacological interventions establish SM as the primary downstream effector mediating glutamine's pro‐tumorigenic effects. Mechanistically, SM accumulation promotes lipid raft formation, which subsequently activates TGF‐β signaling to induce epithelial–mesenchymal transition. This cascade compromises the epithelial integrity of preneoplastic hepatocytes, thereby driving malignant transformation and fueling tumor progression. Collectively, these findings provide a mechanistic rationale cautioning against glutamine supplementation in high‐risk populations and highlight potential novel metabolic vulnerabilities for the prevention and treatment of HCC.

Förderung

  • National Natural Science Foundation of China
  • Kunming Medical University
  • Yunnan University

Zitieren

APA

Huang, Q., Shi, Z., Zhao, J., Mao, X., Tu, Z., Zhang, Y., Sun, Y., Zhu, H., Zhao, C., Yang, P., Zhang, C., Xu, J., Gong, M., Shen, C., Peng, B., Zhong, T., Zhang, Y., Liao, W., He, Y., …, & Wei, Y. (2026). Glutamine Fuels De Novo Sphingomyelin Synthesis to Drive Hepatocellular Carcinoma Development. Advanced Science. https://doi.org/10.1002/advs.78828

Vancouver

Huang Q, Shi Z, Zhao J, Mao X, Tu Z, Zhang Y, et al. Glutamine Fuels De Novo Sphingomyelin Synthesis to Drive Hepatocellular Carcinoma Development. Advanced Science. 2026. doi:10.1002/advs.78828

BibTeX
@article{Huang2026,
  author = {Huang, Qin and Shi, Zhitian and Zhao, Jian and Mao, Xianjiao and Tu, Zhihong and Zhang, Yiwen and Sun, Yue and Zhu, Huiling and Zhao, Chen and Yang, Peng and Zhang, Chen and Xu, Jiashun and Gong, Ming and Shen, Chang and Peng, Bangya and Zhong, Tao and Zhang, Yuezheng and Liao, Weiran and He, Yutao and Tang, Haocheng and Wang, Lin and Wei, Yonglong},
  title = {Glutamine Fuels De Novo Sphingomyelin Synthesis to Drive Hepatocellular Carcinoma Development},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.78828}
}
Kostenlos starten →